PTE - PolarityTE, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

PolarityTE, Inc.

123 North Wright Brothers Drive
Salt Lake City, UT 84116
United States
385-237-2279
http://www.polarityte.com

Sector : Healthcare
Industry : Biotechnology
Full Time Employees : 160

Key Executives

Name Title Pay Exercised Year Born
Dr. Denver M. Lough Chairman, CEO and Chief R&D Officer N/A N/A 1981
Mr. Paul Elliot Mann Chief Financial Officer N/A N/A N/A
Mr. Richard Hague Chief Operating Officer N/A N/A 1960
Dr. David Blum Chief Design & Technology Officer N/A N/A N/A
Mr. Nikolai Sopko Chief Scientific Officer and VP of R&D N/A N/A N/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Corporate Governance

PolarityTE, Inc.’s ISS Governance QualityScore as of April 1, 2019 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) . Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.